SE453961B - Anvendning av substituerad 1,8-dihydroxi-9-antron for framstellning av ett lekemedel for behandling av psoriasis genom anbringande pa huden - Google Patents

Anvendning av substituerad 1,8-dihydroxi-9-antron for framstellning av ett lekemedel for behandling av psoriasis genom anbringande pa huden

Info

Publication number
SE453961B
SE453961B SE8107468A SE8107468A SE453961B SE 453961 B SE453961 B SE 453961B SE 8107468 A SE8107468 A SE 8107468A SE 8107468 A SE8107468 A SE 8107468A SE 453961 B SE453961 B SE 453961B
Authority
SE
Sweden
Prior art keywords
anthron
dihydroxy
psoriasis
treatment
preparation
Prior art date
Application number
SE8107468A
Other languages
English (en)
Swedish (sv)
Other versions
SE8107468L (sv
Inventor
B Shroot
J Maignan
G Lang
Original Assignee
Cird
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cird filed Critical Cird
Publication of SE8107468L publication Critical patent/SE8107468L/
Publication of SE453961B publication Critical patent/SE453961B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
SE8107468A 1980-12-15 1981-12-14 Anvendning av substituerad 1,8-dihydroxi-9-antron for framstellning av ett lekemedel for behandling av psoriasis genom anbringande pa huden SE453961B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8026550A FR2495934A1 (fr) 1980-12-15 1980-12-15 Composition pour le traitement du psoriasis a base d'une dihydroxy-1,8 anthrone-9 substituee en position 10

Publications (2)

Publication Number Publication Date
SE8107468L SE8107468L (sv) 1982-06-16
SE453961B true SE453961B (sv) 1988-03-21

Family

ID=9249080

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8107468A SE453961B (sv) 1980-12-15 1981-12-14 Anvendning av substituerad 1,8-dihydroxi-9-antron for framstellning av ett lekemedel for behandling av psoriasis genom anbringande pa huden

Country Status (11)

Country Link
US (1) US4405615A (ja)
JP (1) JPS57163311A (ja)
BE (1) BE891467A (ja)
CA (1) CA1186228A (ja)
CH (1) CH649708A5 (ja)
DE (1) DE3149528C2 (ja)
FR (1) FR2495934A1 (ja)
GB (1) GB2091999B (ja)
IT (1) IT1142097B (ja)
NL (1) NL8105618A (ja)
SE (1) SE453961B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2565966B1 (fr) * 1984-06-13 1986-08-29 Cird Aryl-10 dihydroxy-1,8 anthrones et leurs esters, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
FR2567402B1 (fr) * 1984-07-12 1988-07-01 Cird Nouvelles compositions pharmaceutiques et cosmetiques contenant comme ingredient actif la dihydroxy-1,8 phenyl-10 anthrone-9, et procede de preparation de l'ingredient actif
AU628304B2 (en) * 1987-10-22 1992-09-17 Victoria University Of Manchester, The New compounds of the anthraquinone series
CA2109515A1 (en) * 1991-05-29 1992-11-30 Robert L. Dow Dihydroxyindanone tyrosine kinase inhibitors
DE4231636A1 (de) * 1992-09-22 1994-03-24 Beiersdorf Ag Neue in 10-Stellung substituierte Anthron- und Anthracen-Derivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende pharmazeutische oder kosmetische Mittel und deren Verwendung
AU4990797A (en) * 1996-10-24 1998-05-15 Alza Corporation Permeation enhancers for transdermal drug delivery compositions, devices, and methods
WO2005055933A2 (en) * 2003-12-03 2005-06-23 Smithkline Beecham Corporation Treatment of psoriasis with rosiglitazone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2256663A1 (de) * 1972-11-18 1974-05-22 Basf Ag Verfahren zur herstellung von chloranthrachinon-2,3-dicarbonsaeureanhydriden
US3835167A (en) * 1972-12-18 1974-09-10 Syntex Inc Anthrone carboxylic acids and derivatives

Also Published As

Publication number Publication date
DE3149528A1 (de) 1982-08-19
CA1186228A (fr) 1985-04-30
JPS57163311A (en) 1982-10-07
US4405615A (en) 1983-09-20
BE891467A (fr) 1982-06-14
CH649708A5 (fr) 1985-06-14
SE8107468L (sv) 1982-06-16
GB2091999B (en) 1984-08-15
IT1142097B (it) 1986-10-08
FR2495934B1 (ja) 1983-06-17
FR2495934A1 (fr) 1982-06-18
NL8105618A (nl) 1982-07-01
IT8125582A0 (it) 1981-12-14
DE3149528C2 (de) 1985-10-31
GB2091999A (en) 1982-08-11

Similar Documents

Publication Publication Date Title
CA1266466A (fr) Procede de preparation de steroides substitues en position 10
US5019567A (en) Benzoyl peroxide--quaternary ammonium lipophilic salicylate based pharmaceutical and cosmetic compositions and their use especially in treatment of acne
DE2513157C2 (ja)
US5175340A (en) New liposoluble unsaturated benzalmalonate derivatives and their use as absorbers for ultraviolet radiation in cosmetics
US4356184A (en) Anti-allergic or antihypertensive 1-piperidinylmethyl benzenamines
KR20160023770A (ko) (s,s)-세코이소라리시레시놀 디글루코사이드 및 (r,r)-세코이소라리시레시놀 디글루코사이드의 제조
SE453961B (sv) Anvendning av substituerad 1,8-dihydroxi-9-antron for framstellning av ett lekemedel for behandling av psoriasis genom anbringande pa huden
Csallany et al. Dimerization of α-tocopherol in vivo
GB1603902A (en) Photocleavable steroid derivatives
JPH0352876A (ja) 薬剤的効果を有する１ｈ―４，１，２―ベンゾキサジアジン誘導体及びその製造法並びに使用法
WO2000078729A1 (en) Crystalline forms of lansoprazole
US4981680A (en) P-hydroxycinnamamide derivatives and melanin inhibitor comprising the same
US4889865A (en) 10-aryl-1,8-dihydroxy-9- anthrones and their esters
SU1508963A3 (ru) Способ получени 11 @ -замещенных стероидов или их фармацевтически или ветеринарно приемлемых солей
DE2039426C3 (de) 1-Benzyliden-indenyl-(3)-essigsäuren, deren nicht-toxische, pharmakologisch verträgliche Salze, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US4755530A (en) 1-hydroxy-8-acyloxy-10-acyl anthrones, process for their preparation and their use in human or veterinary medicines and in cosmetic formulations
EP0079639B1 (en) A new anti-inflammatory drug
Leach Jr et al. Preparation and photochemistry of methyl 3, 3, 4-triphenyl-3H-pyrazole-5-carboxylate
DE1795543B2 (de) Indolyl-(3)-alkancarbonsäure-niedrigalkylester
US3489768A (en) Indole-4-acetic acid compounds
US4223146A (en) 4,5,6,7-Tetrahydroimidazo-[4,5-c]-pyridine derivatives
JP4071466B2 (ja) 新規なオルシノール誘導体
EP0031591A1 (de) 2,2-Dimethyl-3-oxoandrosta-4,6-dien-17S-spiro-5'-(2'-oxo-3'-methyloxazolidin), Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
Tipson et al. Note on the tosylation of diethyl mucate
US2976217A (en) Sunscreening agents

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8107468-4

Effective date: 19930709

Format of ref document f/p: F